Page 107 - 83_02
P. 107

66. Bhise NS, Manoharan V, Massa S, et al. A liver-on-a-      267
     chip platform with bioprinted hepatic spheroids.
     Biofabrication. 2016; 8:014101.

67. Chao P, Maguire T, Novik E, et al. Evaluation of a
     microfluidic based cell culture platform with primary
     human hepatocytes for the prediction of hepatic
     clearance in human. Biochem Pharmacol 2009;
     78:625-632.

68. Goral VN, Hsieh YC, Petzold ON, et al. Perfusion-
     based microfluidic device for three-dimensional
     dynamic primary human hepatocyte cell culture in the
     absence of biological or synthetic matrices or
     coagulants. Lab Chip 2010; 10:3380-3386.

69 Novik E, Maguire TJ, Chao P, et al. A microfluidic
     hepatic coculture platform for cell-based drug
     metabolism studies. Biochem Pharmacol 2010;
     79:1036-1044.

70. Bhushan A, Senutovitch N, Bale SS, et al. Towards a
     three-dimensional microfluidic liver platform for
     predicting drug efficacy and toxicity in humans. Stem
     Cell Res Ther 2013; 4 Suppl 1:S16.

71. Toh Y-C, Lim T C, Tai D, et al. A microfluidic 3D
     hepatocyte chip for drug toxicity testing. 2009; Lab
     Chip 9: 2026-2010.

72. Bavli D, Prill S, Ezra E, et al. Real-time monitoring of
     metabolic function in liver-on-chip microdevices
     tracks the dynamics of mitochondrial dysfunction.
     Proc. Natl. Acad. Sci. U. S. A. 2016; 113:
     E2231-E2240.

73. Zhu W, Ma X, Gou M, et al. 3D printing of functional
     biomaterials for tissue engineering.Curr. Opin.
     Biotechnol. 2016; 40: 103-112.

74. Ma X, Qu X, Zhu W, et al. Deterministically patterned
     biomimetic human iPSC-derived hepatic model via
     rapid 3D bioprinting. Proc. Natl. Acad. Sci. U. S. A
     2016; 113: 2206-2211.

75. Gómez-Lechón MJ, Tolosa L, Donato MT. Metabolic
     activation and drug-induced liver injury: in vitro
     approaches for the safety risk assessment of new
     drugs. J Appl Toxicol. 2016; 36(6):752-768.

76. Las Omicas: Genomica, proteomica, citomica y
     metabolomica. Nuevas Tecnologías para el desarrollo
     de Fármacos. María Cascales Angosto, Mª José
     Gómez-Lechón y Enrique O´Connor, eds. Madrid:
     Instituto de España y Real Academia Nacional de
     Farmacia, Fundación José Casares Gil, 2005.

      @Real Academia Nacional de Farmacia. Spain
   102   103   104   105   106   107   108   109   110   111   112